GlassScriptPhysician profile
Richard Barton
NPI 1770653925
$1,980.07
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $34.13 · 2020: $97.79 · 2021: $291 · 2022: $518 · 2023: $584 · 2024: $454.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,038.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,038.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $385.23 | 2020-2024 | Paragard T 380a, Paragard T 380a |
| Avion Pharmaceuticals | $324.31 | 2020-2023 | Balcoltra |
| Pfizer INC. | $270.15 | 2019-2024 | |
| Sumitomo Pharma America, INC. | $245.50 | 2023-2024 | Myfembree, Gemtesa |
| Abbvie INC. | $169.10 | 2019-2022 | |
| Exeltis, USA INC. | $148.93 | 2022-2024 | Slynd |
| Kerecis Limited | $80.53 | 2023-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Organon LLC | $75.82 | 2022-2024 | Nexplanon |
| Myovant Sciences INC. | $60.43 | 2021-2022 | |
| Therapeuticsmd, INC. | $39.90 | 2021 | |
| Mayne Pharma Commercial LLC | $36.41 | 2023 | |
| Agile Therapeutics, INC. | $32.04 | 2021 | |
| Laborie Medical Technologies Corp. | $28.23 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $28.13 | 2022 | |
| Astellas Pharma US INC | $21.39 | 2024 | Veozah |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $20.64 | 2023 | Arexvy, Shingrix |
| Olympus America INC. | $13.33 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Barton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.